The volatile and heterogeneous gut microbiota shifts of COVID-19 patients over the course of a probiotics-assisted therapy

Clin Transl Med. 2021 Dec;11(12):e643. doi: 10.1002/ctm2.643.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / complications*
  • COVID-19 / physiopathology
  • Gastrointestinal Diseases / drug therapy*
  • Gastrointestinal Diseases / etiology*
  • Gastrointestinal Diseases / physiopathology
  • Gastrointestinal Microbiome / drug effects*
  • Humans
  • Probiotics / therapeutic use*
  • SARS-CoV-2